ClinicalTrials.Veeva

Menu

Low-FODMAP Diet for Functional Abdominal Pain Disorders in Children.

M

Medical University of Warsaw

Status

Terminated

Conditions

Functional Abdominal Pain Disorder

Treatments

Other: Low-FODMAP diet

Study type

Interventional

Funder types

Other

Identifiers

NCT04528914
1W44/5FNUT13/20

Details and patient eligibility

About

This single-center, randomized, controlled, quadruple-blinded, superiority trial is performed to test the hypothesis that children with IBS and FAP-NOS who receive a low-FODMAP diet will have a lower mean abdominal pain intensity score compared with those who receive a regular diet after 4 weeks of intervention.

Full description

Introduction. Evidence from studies in adults documents that fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) may be triggers of symptoms in individuals with functional abdominal pain disorders. However, in children with FAPDs, there is a need for high-quality evidence regarding the dietary management. We aim to assess the effects of a low-FODMAP diet compared with a regular diet for the management of children with FAPDs.

Methods. In this trial, seventy-four children aged 8 to 18 years with a Functional Abdominal Pain Disorder (Irritable Bowel Syndrome or Functional Abdominal Pain-Not Otherwise Specified), diagnosed according to the Rome IV criteria, will be randomly allocated to receive either a low-FODMAP diet or a regular diet for 4 weeks.A primary outcome will be the percentage of the responders, defined as the participants who have at least 30% improvement in abdominal pain intensity on a Visual Analogue Scale (VAS) during the last week of the trial compared with baseline, that is at least equal to the Reliable Change Index (≥ 25 mm change on VAS).

Enrollment

42 patients

Sex

All

Ages

8 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • functional abdominal pain - not otherwise specified (FAP-NOS) or irritable bowel syndrome (IBS) diagnosed according to the Rome IV Criteria,
  • baseline average pain intensity at least 30 mm on a 100-mm Visual Analogue Scale,
  • feeding via the oral route,
  • ability to read and comprehend any employed questionnaires/scales,
  • signed informed consent,
  • stated availability throughout the study period.

Exclusion criteria

  • receiving any other intervention/treatment with regard to FAP-NOS or IBS or those who received any other intervention during the last 3 months,
  • an organic cause of symptoms or organic gastrointestinal disease,
  • chronic illness, receiving medications which affect gastrointestinal motility,
  • need for any other dietary management which could make the balancing or compliance with the diet troublesome,
  • previously diagnosed carbohydrate intolerance without symptoms of FAPD after implementation of an exclusion diet,
  • undernutrition (defined as World Health Organization [WHO] growth charts < -2 SD), decreased growth velocity (sharp decline in growth line), or overweight or obese (> 1 or > 2 SD on the WHO growth charts, respectively),
  • unintentional weight loss greater or equal to 5% of subject' body weight within the previous 3 months,
  • pregnancy,
  • eating disorders,
  • prior surgery of the gastrointestinal tract (within last 3 months),
  • recurrent or unexplained fever,
  • developmental disabilities which impair the ability of the child to understand or communicate.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

42 participants in 2 patient groups

Low-FODMAP diet
Experimental group
Description:
37 participants.
Treatment:
Other: Low-FODMAP diet
Regular diet
No Intervention group
Description:
37 participants. The regular diet will reflect the habitual FODMAP intake in a normal diet. Diets in both groups will be matched in terms of total energy, fat, protein, carbohydrates and dietary fiber with the usual participant's diet.

Trial contacts and locations

1

Loading...

Central trial contact

Agata Stróżyk, MSc; Andrea Horvath, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems